DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zenapax (Daclizumab) - Current Clinical Trials

 
 



Zenapax Related Clinical Trials

Anti-Tac for Treatment of Leukemia [Completed]

A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure [Terminated]

Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk [Completed]

Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) [Completed]

Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration [Completed]

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis [Active, not recruiting]

Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis [Completed]

Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin s Lymphoma [Suspended]

ANTI-TAC THERAPY FOR UVEITIS [Completed]

Thymoglobulin Versus Alemtuzumab Versus Daclizumab in Living Donor Renal Transplantation [Completed]

Zenapax to Treat Multiple Sclerosis [Completed]

A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients [Completed]

To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris [Completed]

Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis [Completed]

To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris [Completed]

Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis [Completed]

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation [Completed]

Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis [Completed]

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists [Active, not recruiting]

Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation [Completed]

Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHD [Completed]

Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis [Completed]

Combination Daclizumab/Denileukin Diftitox to Treat Uveitis [Completed]

Daclizumab and Sirolimus to Treat Uveitis [Completed]

Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis [Completed]

Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant Patients [Recruiting]

A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients [Completed]

Study of Daclizumab in Patients With Chronic, Persistent Asthma [Completed]

MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients [Completed]

Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease [Active, not recruiting]

Efficacy Study of Zenapax in Combination With CellCept, Cyclosporine and Corticosteroids in Heart Transplant [Completed]

The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation [Completed]

Daclizumab to Treat HIV-Infected Patients [Completed]

Daclizumab to Treat Wegener's Granulomatosis [Completed]

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal Transplantation [Completed]

Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Completed]

Daclizumab to Treat Chronic Immune Thrombocytopenia [Completed]

Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) in Participants With Multiple Sclerosis Who Have Completed Study 205MS201 (NCT00390221) to Treat Relapsing-Remitting Multiple Sclerosis. [Completed]

New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial [Active, not recruiting]

Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by Surgery [Completed]

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) [Completed]

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac [Completed]

Daclizumab Experience in Pediatric Heart Transplant [Terminated]

Calcineurin Inhibitor-Free Immunosuppression in Renal Transplant Recipients at Low Immunogenic Risk [Completed]

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients [Completed]

Phase I/II Thymus Transplantation With Immunosuppression #950 [Active, not recruiting]

Study Evaluating Sirolimus in Kidney Transplant Recipients [Completed]

Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols [Completed]

Pediatric Kidney Transplant Without Calcineurin Inhibitors [Completed]

Islet Allotransplantation With Steroid Free Immunosuppression [Completed]

Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Active, not recruiting]

Vaccine Therapy With or Without Recombinant Interleukin-12 Followed by Daclizumab in Treating Patients With Metastatic Melanoma [Active, not recruiting]

Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts [Completed]

B-Lymphocyte Immunotherapy in Islet Transplantation [Terminated]

Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis [Completed]

Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation [Completed]

Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes [Completed]

Monoclonal Antibody Therapy in Treating Patients With Leukemia [Completed]

Prevention of Diabetes Progression Trial (PDPT) [Completed]

Investigating Mechanism of Action of DAC HYP in the Treatment of High-Inflammatory Multiple Sclerosis (MS) [Recruiting]

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas [Completed]

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia [Completed]

Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [Completed]

HAT in Eye Complications of Behcet's Disease [Completed]

LMB-2 to Treat Hairy Cell Leukemia [Recruiting]

Efficacy of Islet After Kidney Transplantation [Active, not recruiting]

Islet Transplantation for Type 1 Diabetes [Completed]

Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis [Withdrawn]

Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX [Completed]

Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch [Recruiting]

Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation. [Completed]

Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA) [Not yet recruiting]

Differences in Genes and Proteins in Active and Controlled Uveitis [Completed]

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant [Withdrawn]

Fibrosis in Renal Allografts [Recruiting]

Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection [Active, not recruiting]

Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Completed]

Multicenter Uveitis Steroid Treatment (MUST) Trial [Completed]

Immunotoxin in Treating Patients With Leukemia or Lymphoma [Completed]

Fludarabine and Cyclophosphamide Followed By LMB-2 Immunotoxin in Treating Patients With Hodgkin's Lymphoma [Withdrawn]

Multipeptide Vaccine for Advanced Breast Cancer [Completed]

Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes [Completed]

Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus [Withdrawn]

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia [Recruiting]

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression [Active, not recruiting]

Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression [Active, not recruiting]

Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation [Active, not recruiting]

Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation [Completed]

Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys [Completed]

Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia [Completed]

Simulect Versus ATG in Sensitized Renal Transplant Patient [Recruiting]

Minimizing Immunosuppression in Old for Old Kidney Transplantation [Completed]

Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium [Completed]

Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen [Completed]

Kidney Transplantation in Patients With Cystinosis [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017